Oncology NEWS International Vol 19 No 9

September 07, 2010

The brothers of men with prostate cancer face a higher disease risk because of increased diagnostic activity, and not necessarily because they carry a genetic mutation that increases risk of the disease, according to a Swedish study.

September 02, 2010

Practical Radiation Oncology, a quarterly journal from ASTRO, is now accepting manuscripts.

September 02, 2010

Esophagitis is a known adverse effect of bisphosphonate use and reflux esophagitis is an established risk factor for esophageal cancer through the Barrett pathway.

September 02, 2010

Radiation oncologist Jonathan J. Beitler, MD, MBA, offers the radiation oncology perspective on the array of treatment combinations in this complex disease.

September 02, 2010

New studies show dramatic results in overall and progression-free survival, but not all patients will benefit from aggressive treatment.

September 02, 2010

Combined with first-line chemotherapy, intravenous delivery therapy also confers a survival benefit over oral bisphosphonates. Gareth J. Morgan, MD, PhD, lead investigator of the Medical Research Council Myeloma IX study, will share additional trial results at ASH 2010.

September 01, 2010

Ipilimumab has received FDA priority review status, according to Bristol-Myers Squibb. The review will focus on use of the drug in adult patients with previously treated advanced melanoma.

September 01, 2010

ASTRO bestows multiple awards in time for its 2010 meeting. Learn more about the latest appointments and accolades in the cancer community.

September 01, 2010

ASTRO has published evidence-based guidelines to define appropriate fractionation of whole-breast irradiation.

September 01, 2010

St. Luke’s Episcopal Hospital has established the Philip A. Salem, MD, Chair in Cancer Research.

September 01, 2010

An advisory panel recommended revoking bevacizumab’s approval in breast cancer. Oncologists and patients express concern about what the future holds for those who do benefit from bevacizumab.

September 01, 2010

This rare cancer finally sheds its FDA designation as an orphan disease.

September 01, 2010

Stephen Lutz, MD, talks about the evolution of the ASTRO guideline and how it answers vital questions for radiation oncologists.

September 01, 2010

Male sex, but not race, predicted colon polyp prevalence, suggesting that African Americans may not benefi t from earlier screening.

September 01, 2010

More than 700,000 biopsies are performed in the U.S. every year, but the technology has not always kept pace with cancer diagnosis and therapy. A new technique allows rapid and easy access to the marrow space.

August 31, 2010

Published trial results fail to offer information that oncologists need for clinical translation.